Business Description
![Epsilon Healthcare Ltd Epsilon Healthcare Ltd logo](https://static.gurufocus.com/logos/0C0000B8Q9.png?14)
Epsilon Healthcare Ltd
ISIN : AU0000137598
Compare
Compare
Traded in other countries / regions
EPN.Australia9TH0.GermanyHDRPF.USA IPO Date
2017-05-04Description
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | -0.87 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -4.89 | |||||
Beneish M-Score | -2.82 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.6 | |||||
3-Year EBITDA Growth Rate | 24.9 | |||||
3-Year EPS without NRI Growth Rate | 25.1 | |||||
3-Year FCF Growth Rate | 46.1 | |||||
3-Year Book Growth Rate | -42.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | 9.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.54 | |||||
Quick Ratio | 0.52 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 27.18 | |||||
Days Sales Outstanding | 142.28 | |||||
Days Payable | 242.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.2 | |||||
Shareholder Yield % | 9.55 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 31.18 | |||||
Operating Margin % | -85.75 | |||||
Net Margin % | -82.17 | |||||
FCF Margin % | -36.97 | |||||
ROE % | -61.33 | |||||
ROA % | -30.61 | |||||
ROIC % | -33.41 | |||||
ROC (Joel Greenblatt) % | -36.6 | |||||
ROCE % | -43.16 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.14 | |||||
PB Ratio | 0.77 | |||||
Price-to-Tangible-Book | 0.8 | |||||
EV-to-EBIT | -1.76 | |||||
EV-to-EBITDA | -3.02 | |||||
EV-to-Revenue | 1.34 | |||||
EV-to-FCF | -3.63 | |||||
Earnings Yield (Greenblatt) % | -56.82 | |||||
FCF Yield % | -37 |